STOCK TITAN

PCVX (PCVX) insider James Wassil files planned sales totaling $566,913.91

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PCVX insider reported planned sales of company common stock. The filing lists two sale notices: 7,395 shares for $435,438.31 dated 03/10/2026 and 2,250 shares for $131,475.60 dated 04/01/2026, totaling $566,913.91. The filing also lists recent issuer vesting events (RSU and ESPP) with specified share counts and vesting dates.

Positive

  • None.

Negative

  • None.
Shares sold (first notice) 7,395 shares sale dated 03/10/2026
Proceeds (first notice) $435,438.31 amount shown for 03/10/2026 sale
Shares sold (second notice) 2,250 shares sale dated 04/01/2026
Proceeds (second notice) $131,475.60 amount shown for 04/01/2026 sale
Total proceeds (sum of notices) $566,913.91 aggregate of listed sale amounts
RSU vest (Mar 2, 2025) 743 shares RSU Vest dated 03/02/2025
ESPP (May 16, 2025) 329 shares ESPP dated 05/16/2025
RSU vest (Aug 31, 2025) 1,178 shares RSU Vest dated 08/31/2025
Form 144 regulatory
"Securities Sold During The Past 3 Months — James Wassil entries"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
RSU Vest financial
"03/02/2025 | RSU Vest | Issuer | 743"
ESPP financial
"05/16/2025 | ESPP | Issuer | 329"
An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.
Issuer regulatory
"RSU Vest | Issuer and ESPP | Issuer entries"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the PCVX Form 144 report show?

It reported planned sales totaling $566,913.91 across two notices. The filing lists 7,395 shares for $435,438.31 (03/10/2026) and 2,250 shares for $131,475.60 (04/01/2026). It also records issuer vesting events (RSU and ESPP) with dates and share counts.

Who is the reporting person on the PCVX filing?

The filing identifies James Wassil as the reporting person. The address shown is 825 Industrial Road, Ste. 300, San Carlos, CA. The sale notices and amounts are associated with that reporting person in the Form 144 excerpt.

What recent equity vesting events are listed in the PCVX excerpt?

The excerpt lists RSU and ESPP vesting events with share counts and dates. Examples: RSU vest on 03/02/2025 for 743 shares, ESPP on 05/16/2025 for 329 shares, and RSU vest on 08/31/2025 for 1,178 shares.

Are the dollar amounts in the PCVX filing proceeds or estimates?

The filing shows aggregate dollar figures tied to the listed sales. It records $435,438.31 and $131,475.60 linked to the specific sale dates and share counts; the excerpt does not state additional use or allocation of proceeds.